Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFPROZIL vs CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFPROZIL vs CEFTAZIDIME: Safety Overview

Metric CEFPROZIL CEFTAZIDIME
Total FAERS Reports 337 3,158
Deaths Reported 6 696
Death Rate 1.8% 22.0%
Hospitalizations 95 1,503
Average Patient Age 48.0 yrs 52.0 yrs
% Female Patients 69.1% 43.3%
FDA Approval Date Apr 9, 2024 Apr 28, 1989
Manufacturer Teva Pharmaceuticals USA, Inc. Hospira, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued